S100A4 and cancer: Another study demonstrated that FGF2/FGFR1 mediate triple-negative breast cancer (TNBC) cells to upregulate and secret S100A4 to adapt vascular endothelial cells and trigger motility of cancer-associated fibroblasts [11].